Literature DB >> 9360254

Comparative effects of levofloxacin and ofloxacin on the normal oral and intestinal microflora.

C Edlund1, S Sjöstedt, C E Nord.   

Abstract

The aim of the study was to study the ecological effects of levofloxacin, compared to that of ofloxacin, on the oral and intestinal human microflora. 10 healthy volunteers received levofloxacin (500 mg) and 10 subjects were given ofloxacin (400 mg) perorally, once daily for 7 days. Saliva and stool samples were obtained prior to drug administration, during administration (days 2, 4 and 7), and after withdrawal of the agents (days 9, 11, 14 and 21). The concentrations of levofloxacin and ofloxacin in the saliva and faecal samples, respectively, were assayed, and quantitative and qualitative microbiological analyses were performed. Oral administration of levofloxacin and ofloxacin led to low drug concentrations in the saliva, which corresponded with mild disturbances in the oral microflora. High drug levels were obtained in the intestinal tract, and both agents caused a selective reduction in the normal microflora, mainly directed towards aerobic Gram-negative bacteria. There was no significant difference between levofloxacin and ofloxacin, regarding ecological effects on the normal oral and intestinal microflora. From an ecological point of view, these agents acted favourably, since no major selection of resistant strains occurred in the normal microflora during administration.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9360254     DOI: 10.3109/00365549709011835

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  16 in total

1.  Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients.

Authors:  C J Donskey; T K Chowdhry; M T Hecker; C K Hoyen; J A Hanrahan; A M Hujer; R A Hutton-Thomas; C C Whalen; R A Bonomo; L B Rice
Journal:  N Engl J Med       Date:  2000-12-28       Impact factor: 91.245

2.  Impact of a fluoroquinolone formulary change on acquisition of quinolone-resistant gram-negative bacilli.

Authors:  B N Hota; S Pur; L Phillips; R A Weinstein; J Segreti
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-06       Impact factor: 3.267

3.  Effects of single oral doses of gemifloxacin (320 milligrams) versus trovafloxacin (200 milligrams) on fecal flora in healthy volunteers.

Authors:  G Garcia-Calvo; A Molleja; M J Giménez; A Parra; E Nieto; C Ponte; L Aguilar; F Soriano
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

4.  DAV131A Protects Hamsters from Lethal Clostridioides difficile Infection Induced by Fluoroquinolones.

Authors:  Nathalie Saint-Lu; Charles Burdet; Frédérique Sablier-Gallis; Tanguy Corbel; Agathe Nevière; Sakina Sayah-Jeanne; Mark Pulse; William Weiss; Stéphanie Ferreira; Antoine Andremont; France Mentré; Jean de Gunzburg
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

Review 5.  Effect of quinolones on intestinal ecology.

Authors:  C Edlund; C E Nord
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 6.  Ofloxacin. A reappraisal of its use in the management of genitourinary tract infections.

Authors:  S V Onrust; H M Lamb; J A Balfour
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

Review 7.  Levofloxacin: an updated review of its use in the treatment of bacterial infections.

Authors:  Miriam Hurst; Harriet M Lamb; Lesley J Scott; David P Figgitt
Journal:  Drugs       Date:  2002       Impact factor: 9.546

8.  Effects of exposure of Clostridium difficile PCR ribotypes 027 and 001 to fluoroquinolones in a human gut model.

Authors:  Katie Saxton; Simon D Baines; Jane Freeman; Rachael O'Connor; Mark H Wilcox
Journal:  Antimicrob Agents Chemother       Date:  2008-08-18       Impact factor: 5.191

9.  Effect of parenteral fluoroquinolone administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract.

Authors:  Curtis J Donskey; Marion S Helfand; Nicole J Pultz; Louis B Rice
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

Review 10.  Human gut microbiota: repertoire and variations.

Authors:  Jean-Christophe Lagier; Matthieu Million; Perrine Hugon; Fabrice Armougom; Didier Raoult
Journal:  Front Cell Infect Microbiol       Date:  2012-11-02       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.